Veterinary Vaccines Market by Disease (Swine Pneumonia, Avian Influenza, Rabies, Coccidiosis, Brucellosis, Canine Distemper), Type (Poultry, Livestock, Aquaculture, Porcine, Canine), Technology (Inactivated, Toxoid, Recombinant) - Global Forecasts to 2025
Updated on : February 20, 2023
The global veterinary vaccines market in terms of revenue was estimated to be worth $8.0 billion in 2020 and is poised to reach $11.3 billion by 2025, growing at a CAGR of 7.2% from 2020 to 2025. The growth of this market is driven majorly by the increase in the companion animal population, rising incidence of zoonotic diseases, initiatives by various government agencies and animal associations to maintain animal health, and the rising demand for animal-derived food products are driving the growth of this market. On the other hand, the high storage cost of vaccines is restraining market growth.
Porcine circovirus II held the largest share of the porcine vaccines market, by type
Based on disease, the porcine vaccines market is segmented into porcine reproductive and respiratory syndrome (PRRS), porcine circovirus II, porcine parvovirus, swine influenza, swine pneumonia, and other porcine diseases. In 2019, the porcine circovirus II segment dominated this market owing to the high and growing prevalence of the infection.
The Asia Pacific veterinary vaccines market is expected to grow at the highest CAGR during the forecast period
The Asia Pacific is expected to grow at the highest rate in the global market. The major factors driving the growth of this market include the rising pet adoption, expansion of key vaccine players, increasing product availability, and investments in manufacturing facilities in various Asia Pacific countries, especially in India, China, and Thailand.
The prominent players in the global market include Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), and Virbac SA (France). Major players have focused on product launches, agreements, and partnerships to increase their shares in the global veterinary vaccines market.
Boehringer Ingelheim is one of the leading players in the global market. The company’s leading position can be attributed to its extensive portfolio of veterinary vaccines and a strong geographical footprint. The company operates in over 130 countries across the Americas, Europe, Asia, and Africa. The company’s key advantage over its competitors is that it leverages various opportunities in high-growth and emerging markets, such as Asia, Australia, and Africa. This can be reflected in the company’s strong performance in these markets, which represented over 23.6% of its total revenue in 2018.
Veterinary Vaccines Market Report Scope:
|
Report Metric |
Details |
|
Market size available for years |
2018–2025 |
|
Base year considered |
2019 |
|
Forecast period |
2020–2025 |
|
Forecast units |
Value (USD) |
|
Segments covered |
Technology, Type, Disease, and Region |
|
Geographies covered |
North America, Europe, Asia Pacific, and Rest of the World |
|
Companies covered |
Zoetis (US), Merck Animal Health (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (US), Virbac (France), Vetoquinol (France), Phibro Animal Health (US), Hester Biosciences (India), HIPRA (Spain), Biogenesis Bago (Argentina), Tianjin Ringpu (China), China Animal Husbandry (China), Jinyu Bio-technology (China), Endovac Animal Health (US), Brilliant Bio Pharma Private Limited (India), Aptimmune Biologics (US), Indian Immunologicals Ltd. (India), Torigen (US), and VEROVACCiNES (Germany). |
The research report categorizes the veterinary vaccines market into the following segments and sub-segments:
By Type
- Porcine Vaccines
- Poultry Vaccine
-
Livestock Vaccine
- Bovine Vaccines
- Small Ruminant Vaccines
-
Companion Animal Vaccine
- Canine Vaccine
- Feline Vaccine
- Aquaculture Vaccines
- Other Animal Vaccines
By Disease
- Porcine
- Poultry
-
Livestock
- Bovine
- Small Ruminant
-
Companion Animal
- Canine
- Feline
- Aquaculture
By Technology
- Live Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Other Vaccines
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- RoE
-
Asia Pacific
- China
- Japans
- India
- Thailand
- Rest of Asia Pacific
-
Rest of the World
- Latin America
- Middle East and Africa
Recent Developments:
- In 2020, Merck Animal Health signed a partnership agreement with Automazioni VX, Inc. (US). This partnership was aimed at the introduction of Innoject Pro, a newly designed subcutaneous chick vaccination technology. The technology will be utilized in combination with Merck Animal Health’s Innovax range of vaccines, which is used for protection against infectious diseases in poultry.
- In 2019, Pharmaq (a part of Zoetis) signed a partnership agreement with Caritas (US). This partnership aims to improve the productivity and sustainability of the value chain of tilapia fish in the country. Also, the partnership will provide training for tilapia farmers in fish health management and best aquaculture practices.
- In 2019, Elanco signed an agreement with Bayer’s Animal Health Business to acquire its Animal Health business in a transaction valued at USD 7.6 billion.
Critical questions answered in the report:
- Which regions are likely to grow at the highest CAGR?
- What are the recent trends affecting the veterinary vaccines market?
- Who are the key players in the market, and how intense is the competition?
- What are the application areas of veterinary vaccine devices?
- What are the challenges hindering the adoption of veterinary vaccines?
Frequently Asked Questions (FAQs):
What is the size of Veterinary Vaccines Market ?
The global veterinary vaccines market is projected to reach USD 11.3 billion by 2025, growing at a CAGR of 7.2%.
What are the major growth factors of Veterinary Vaccines Market ?
The growth of this market is driven majorly by the increase in the companion animal population, rising incidence of zoonotic diseases, initiatives by various government agencies and animal associations to maintain animal health, and the rising demand for animal-derived food products are driving the growth of this market. On the other hand, the high storage cost of vaccines is restraining market growth.
Who all are the prominent players of Veterinary Vaccines Market ?
The prominent players in the veterinary vaccines market include Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), and Virbac SA (France). Major players have focused on product launches, agreements, and partnerships to increase their shares in the global veterinary vaccines market. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 20)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. - 24)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.2.3 GROWTH FORECAST
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 30)
4 PREMIUM INSIGHTS (Page No. - 33)
4.1 VETERINARY VACCINES MARKET OVERVIEW
4.2 NORTH AMERICA: VETERINARY VACCINES MARKET, BY TECHNOLOGY (2019)
4.3 SHARES OF MAJOR REGIONAL SEGMENTS IN THE VETERINARY VACCINES MARKET
5 MARKET OVERVIEW (Page No. - 36)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growth in the companion animal population
5.2.1.2 Rising incidence of zoonotic diseases
5.2.1.3 Initiatives by various government agencies and animal associations
5.2.1.4 Rising demand for animal-derived food products
5.2.2 RESTRAINTS
5.2.2.1 High storage cost of vaccines
5.2.3 OPPORTUNITIES
5.2.3.1 Technological advancements
5.2.4 CHALLENGES
5.2.4.1 Inadequate surveillance and reporting systems
6 VETERINARY VACCINES MARKET, BY TYPE (Page No. - 41)
6.1 INTRODUCTION
6.2 PORCINE VACCINES
6.2.1 PORCINE VACCINES SEGMENT DOMINATED THE MARKET IN 2019
6.3 POULTRY VACCINES
6.3.1 INCREASED PRODUCTION AND REARING OF POULTRY TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
6.4 LIVESTOCK VACCINES
6.4.1 BOVINE VACCINES
6.4.1.1 Bovine vaccines segment dominated the livestock vaccines market in 2019
6.4.2 SMALL RUMINANT VACCINES
6.4.2.1 Clostridial diseases and scabby mouth infection are some of the major diseases affecting small ruminants
6.5 COMPANION ANIMAL VACCINES
6.5.1 CANINE VACCINES
6.5.1.1 Canine vaccines segment dominated the companion animal vaccines market in 2019
6.5.2 FELINE VACCINES
6.5.2.1 Rising prevalence of zoonotic diseases to drive the demand for feline vaccines
6.6 AQUACULTURE VACCINES
6.6.1 VACCINATION PLAYS A CRUCIAL ROLE IN COMMERCIAL FISH FARMING
6.7 OTHER ANIMAL VACCINES
7 VETERINARY VACCINES MARKET, BY DISEASE (Page No. - 58)
7.1 INTRODUCTION
7.2 PORCINE DISEASES
7.3 POULTRY DISEASES
7.4 LIVESTOCK DISEASES
7.4.1 BOVINE DISEASES
7.4.2 SMALL RUMINANT DISEASES
7.5 COMPANION ANIMAL DISEASES
7.5.1 CANINE DISEASES
7.5.2 FELINE DISEASES
7.6 AQUACULTURE DISEASES
8 VETERINARY VACCINES MARKET, BY TECHNOLOGY (Page No. - 76)
8.1 INTRODUCTION
8.2 LIVE ATTENUATED VACCINES
8.2.1 LIVE ATTENUATED VACCINES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2019
8.3 INACTIVATED VACCINES
8.3.1 RISING NEED TO DEVELOP ARTIFICIAL IMMUNITY AGAINST DISEASES FROM NON-LIVING PATHOGENS IS A KEY FACTOR DRIVING THE GROWTH OF THE INACTIVATED VACCINES MARKET
8.4 TOXOID VACCINES
8.4.1 TOXOID VACCINES ARE USED WHEN A BACTERIAL TOXIN CAUSES AN ILLNESS
8.5 RECOMBINANT VACCINES
8.5.1 ADVANTAGES ASSOCIATED WITH RECOMBINANT VACCINES DRIVING THEIR DEMAND
8.6 OTHER VACCINES
9 VETERINARY VACCINES MARKET, BY REGION (Page No. - 86)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 US is the largest market for veterinary vaccines in North America
9.2.2 CANADA
9.2.2.1 Rising pet and livestock populations in Canada to support market growth
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Germany dominated the European veterinary vaccines market in 2019
9.3.2 UK
9.3.2.1 Growing pet adoption is increasing the demand for veterinary vaccines in the UK
9.3.3 FRANCE
9.3.3.1 Rising pet ownership to support market growth in France
9.3.4 ITALY
9.3.4.1 Increasing outbreaks of diseases to support market growth in Italy
9.3.5 SPAIN
9.3.5.1 Increase in the number of veterinary practices and the willingness to spend on animal healthcare to drive market growth in Spain
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.1.1 Outbreak of COVID-19 to affect the overall companion animal market in China
9.4.2 JAPAN
9.4.2.1 Increasing expenditure on pet healthcare to drive market growth in Japan
9.4.3 INDIA
9.4.3.1 Dearth of veterinarians to restrain market growth in India
9.4.4 THAILAND
9.4.4.1 Thailand is a major market for porcine vaccines in the Asia Pacific
9.4.5 REST OF APAC
9.5 REST OF THE WORLD
10 COMPETITIVE LANDSCAPE (Page No. - 134)
10.1 OVERVIEW
10.2 MARKET RANKING ANALYSIS
10.3 COMPETITIVE SCENARIO
10.4 COMPETITIVE LEADERSHIP MAPPING, 2019
10.4.1 VISIONARY LEADERS
10.4.2 INNOVATORS
10.4.3 DYNAMIC DIFFERENTIATORS
10.4.4 EMERGING COMPANIES
11 COMPANY PROFILES (Page No. - 141)
(Business Overview, Products Offered, Recent Developments, Competitive Analysis)*
11.1 ZOETIS
11.2 MERCK ANIMAL HEALTH
11.3 BOEHRINGER INGELHEIM
11.4 ELANCO
11.5 CEVA
11.6 VIRBAC
11.7 VETOQUINOL
11.8 PHIBRO ANIMAL HEALTH
11.9 HESTER BIOSCIENCES
11.10 HIPRA
11.11 BIOGENESIS BAGO
11.12 TIANJIN RINGPU
11.13 CHINA ANIMAL HUSBANDRY
11.14 JINYU BIO-TECHNOLOGY
11.15 OTHER COMPANIES
11.15.1 ENDOVAC ANIMAL HEALTH
11.15.2 BRILLIANT BIO PHARMA PRIVATE LIMITED
11.15.3 APTIMMUNE BIOLOGICS
11.15.4 INDIAN IMMUNOLOGICALS LTD.
11.15.5 TORIGEN
11.15.6 VEROVACCINES
* Business Overview, Products Offered, Recent Developments, Competitive Analysis might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 174)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
LIST OF TABLES (238 Tables)
TABLE 1 PERCENTAGE OF PET OWNERSHIP, BY REGION, 2017
TABLE 2 SMALL COMPANION ANIMAL POPULATION, BY COUNTRY, 2014 VS. 2016 VS. 2018 (MILLION)
TABLE 3 PAST AND PROJECTED TRENDS IN THE CONSUMPTION PATTERN OF MEAT AND MILK IN DEVELOPED AND DEVELOPING COUNTRIES
TABLE 4 VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 5 PORCINE VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 6 NORTH AMERICA: PORCINE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 7 EUROPE: PORCINE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 8 ASIA PACIFIC: PORCINE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 9 POULTRY VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 10 NORTH AMERICA: POULTRY VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 EUROPE: POULTRY VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 12 ASIA PACIFIC: POULTRY VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 13 LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 14 LIVESTOCK VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 15 NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 16 EUROPE: LIVESTOCK VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 17 ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 18 BOVINE VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 19 NORTH AMERICA: BOVINE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 20 EUROPE: BOVINE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 21 ASIA PACIFIC: BOVINE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 SMALL RUMINANT VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 23 NORTH AMERICA: SMALL RUMINANT VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24 EUROPE: SMALL RUMINANT VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 25 ASIA PACIFIC: SMALL RUMINANT VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 26 COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 27 COMPANION ANIMAL VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 28 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 29 EUROPE: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 30 ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 31 CANINE VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 32 NORTH AMERICA: CANINE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 33 EUROPE: CANINE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34 ASIA PACIFIC: CANINE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 35 FELINE VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: FELINE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 EUROPE: FELINE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 38 ASIA PACIFIC: FELINE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 39 AQUACULTURE VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 40 NORTH AMERICA: AQUACULTURE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 41 EUROPE: AQUACULTURE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 42 ASIA PACIFIC: AQUACULTURE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 43 OTHER ANIMAL VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 44 NORTH AMERICA: OTHER ANIMAL VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 45 EUROPE: OTHER ANIMAL VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 46 ASIA PACIFIC: OTHER ANIMAL VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 47 PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 48 PORCINE CIRCOVIRUS II VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 49 NORTH AMERICA: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 50 EUROPE: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 51 ASIA PACIFIC: PORCINE CIRCOVIRUS II VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 52 PRRS VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 53 NORTH AMERICA: PRRS VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 54 EUROPE: PRRS VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 55 ASIA PACIFIC: PRRS VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 56 PORCINE PARVOVIRUS VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 57 NORTH AMERICA: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 58 EUROPE: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 59 ASIA PACIFIC: PORCINE PARVOVIRUS VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 60 SWINE INFLUENZA VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 61 NORTH AMERICA: SWINE INFLUENZA VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 62 EUROPE: SWINE INFLUENZA VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 63 ASIA PACIFIC: SWINE INFLUENZA VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 64 POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 65 INFECTIOUS BRONCHITIS VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 66 NORTH AMERICA: INFECTIOUS BRONCHITIS VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 67 EUROPE: INFECTIOUS BRONCHITIS VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 68 ASIA PACIFIC: INFECTIOUS BRONCHITIS VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 69 AVIAN INFLUENZA VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 70 NORTH AMERICA: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 71 EUROPE: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 72 ASIA PACIFIC: AVIAN INFLUENZA VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 73 NEWCASTLE DISEASE VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 74 NORTH AMERICA: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 75 EUROPE: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 76 ASIA PACIFIC: NEWCASTLE DISEASE VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 77 COCCIDIOSIS VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 78 NORTH AMERICA: COCCIDIOSIS VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 79 EUROPE: COCCIDIOSIS VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 80 ASIA PACIFIC: COCCIDIOSIS VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 81 BOVINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 82 FOOT-AND-MOUTH DISEASE VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 83 BOVINE VIRAL DIARRHEA VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 84 BOVINE CLOSTRIDIAL DISEASES VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 85 BRUCELLOSIS VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 86 INFECTIOUS BOVINE RHINOTRACHEITIS VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 87 SMALL RUMINANT VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 88 CANINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 89 FELINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 90 AQUACULTURE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 91 VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 92 LIVE ATTENUATED VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 93 NORTH AMERICA: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 94 EUROPE: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 95 ASIA PACIFIC: LIVE ATTENUATED VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 96 INACTIVATED VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 97 NORTH AMERICA: INACTIVATED VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 98 EUROPE: INACTIVATED VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 99 ASIA PACIFIC: INACTIVATED VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 100 TOXOID VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 101 NORTH AMERICA: TOXOID VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 102 EUROPE: TOXOID VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 103 ASIA PACIFIC: TOXOID VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 104 RECOMBINANT VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 105 NORTH AMERICA: RECOMBINANT VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 106 EUROPE: RECOMBINANT VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 107 ASIA PACIFIC: RECOMBINANT VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 108 OTHER VACCINES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 109 NORTH AMERICA: OTHER VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 110 EUROPE: OTHER VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 111 ASIA PACIFIC: OTHER VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 112 GLOBAL MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 113 NORTH AMERICA: VETERINARY VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 114 NORTH AMERICA: MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 115 NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 116 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 NORTH AMERICA: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 118 NORTH AMERICA: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 119 NORTH AMERICA: BOVINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 120 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 121 US: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122 US: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123 US: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 124 US: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 125 US: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 126 US: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 127 CANADA: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128 CANADA: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 129 CANADA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 130 CANADA: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 131 CANADA: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 132 CANADA: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 133 EUROPE: NUMBER OF VETERINARIANS, BY COUNTRY, 2013–2017
TABLE 134 EUROPE: VETERINARY VACCINES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 135 EUROPE: MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 136 EUROPE: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 137 EUROPE: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 138 EUROPE: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 139 EUROPE: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 140 EUROPE: BOVINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 141 EUROPE: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 142 GERMANY: COMPANION ANIMAL POPULATION, 2010–2018 (MILLION)
TABLE 143 GERMANY: DISEASE OUTBREAKS IN 2018
TABLE 144 GERMANY: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 145 GERMANY: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 146 GERMANY: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 147 GERMANY: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 148 GERMANY: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 149 GERMANY: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 150 UK: COMPANION ANIMAL POPULATION, 2010–2018 (MILLION)
TABLE 151 UK: ANIMAL DISEASE OUTBREAKS IN 2018
TABLE 152 UK: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 153 UK: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 154 UK: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 155 UK: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 156 UK: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 157 UK: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 158 FRANCE: ANIMAL DISEASE OUTBREAKS IN 2018
TABLE 159 FRANCE: NUMBER OF VETERINARIANS, 2014 VS. 2016 VS. 2018
TABLE 160 FRANCE: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 161 FRANCE: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 162 FRANCE: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 163 FRANCE: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 164 FRANCE: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 165 FRANCE: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 166 ITALY: COMPANION ANIMAL POPULATION, 2010–2018 (MILLION)
TABLE 167 ITALY: NUMBER OF VETERINARIANS, 2012 VS. 2018
TABLE 168 ITALY: ANIMAL DISEASE OUTBREAKS IN 2018
TABLE 169 ITALY: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 170 ITALY: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 171 ITALY: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 172 ITALY: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 173 ITALY: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 174 ITALY: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 175 SPAIN: ANIMAL DISEASE OUTBREAKS IN 2018
TABLE 176 SPAIN: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 177 SPAIN: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 178 SPAIN: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 179 SPAIN: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 180 SPAIN: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 181 SPAIN: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 182 REST OF EUROPE: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 183 REST OF EUROPE: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 184 REST OF EUROPE: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 185 REST OF EUROPE: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 186 REST OF EUROPE: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 187 REST OF EUROPE: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 188 ASIA PACIFIC: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 189 ASIA PACIFIC: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 190 ASIA PACIFIC: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 191 ASIA PACIFIC: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 192 ASIA PACIFIC: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 193 ASIA PACIFIC: BOVINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 194 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 195 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 196 CHINA: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 197 CHINA: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 198 CHINA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 199 CHINA: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 200 CHINA: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 201 CHINA: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 202 PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS IN JAPAN (2000 VS. 2030) (THOUSAND METRIC TONS)
TABLE 203 JAPAN: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 204 JAPAN: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 205 JAPAN: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 206 JAPAN: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 207 JAPAN: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 208 JAPAN: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 209 PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS IN INDIA (2000 VS. 2030) (THOUSAND METRIC TONS)
TABLE 210 INDIA: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 211 INDIA: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 212 INDIA: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 213 INDIA: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 214 INDIA: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 215 INDIA: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 216 THAILAND: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 217 THAILAND: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 218 THAILAND: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 219 THAILAND: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 220 THAILAND: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 221 THAILAND: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 222 ROAPAC: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 223 ROAPAC: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 224 ROAPAC: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 225 ROAPAC: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 226 ROAPAC: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 227 ROAPAC: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 228 ROW: VETERINARY VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 229 ROW: LIVESTOCK VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 230 ROW: COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 231 ROW: PORCINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 232 ROW: POULTRY VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 233 ROW: BOVINE VACCINES MARKET, BY DISEASE, 2018–2025 (USD MILLION)
TABLE 234 ROW: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 235 RANK OF COMPANIES IN THE GLOBAL MARKET, 2019
TABLE 236 AGREEMENTS, PARTNERSHIPS, AND JOINT VENTURES (2017–2020)
TABLE 237 ACQUISITIONS (2017–2019)
TABLE 238 EXPANSIONS (2017–2020)
LIST OF FIGURES (25 Figures)
FIGURE 1 RESEARCH DESIGN: VETERINARY VACCINES MARKET
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 4 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION METHODOLOGY
FIGURE 6 GLOBAL MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 7 GLOBAL MARKET, BY TECHNOLOGY, 2020 VS. 2025 (USD MILLION)
FIGURE 8 PORCINE VACCINES MARKET, BY DISEASE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 GLOBAL MARKET: REGIONAL SNAPSHOT
FIGURE 10 GROWTH IN THE COMPANION ANIMAL POPULATION TO DRIVE MARKET GROWTH
FIGURE 11 LIVE ATTENUATED VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2019
FIGURE 12 NORTH AMERICA IS THE LARGEST REGIONAL MARKET FOR VETERINARY VACCINES
FIGURE 13 GLOBAL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14 NORTH AMERICA: MARKET SNAPSHOT
FIGURE 15 ASIA PACIFIC: MARKET SNAPSHOT
FIGURE 16 COMPETITIVE LEADERSHIP MAPPING: GLOBAL MARKET
FIGURE 17 ZOETIS: COMPANY SNAPSHOT (2019)
FIGURE 18 MERCK & CO., INC.: COMPANY SNAPSHOT (2019)
FIGURE 19 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT (2019)
FIGURE 20 ELANCO: COMPANY SNAPSHOT (2019)
FIGURE 21 CEVA: COMPANY SNAPSHOT (2017)
FIGURE 22 VIRBAC: COMPANY SNAPSHOT (2018)
FIGURE 23 VETOQUINOL: COMPANY SNAPSHOT (2018)
FIGURE 24 PHIBRO ANIMAL HEALTH: COMPANY SNAPSHOT (2019)
FIGURE 25 HESTER BIOSCIENCES: COMPANY SNAPSHOT (2019)
The veterinary vaccines market study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for this extensive, technical, market-oriented, and commercial study of the veterinary vaccines market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the veterinary vaccines market. Primary sources from the demand side included industry experts, such as researchers & scientists. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The veterinary vaccines market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by technology, application, and region).
Data Triangulation
After arriving at the market size, the veterinary vaccines market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments.
Objectives of the Study
- To define, describe, segment, and forecast the global veterinary vaccines market by technology, type, disease, and region
- To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the veterinary vaccines market in five main regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World
- To profile key players in the global veterinary vaccines market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as product/service launches, partnerships, and collaborations in the veterinary vaccines market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (Up to 3)
Growth opportunities and latent adjacency in Veterinary Vaccines Market